LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
Conditions
Hypertrophic Cardiomyopathy (HCM)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Angers, Angers, France
Contact: Study coordinator (Loïc BIERE)CHU Bordeaux Haut-Levêque, Bordeaux, France
Contact: Study coordinator (Patricia Reant, Pr)CHU Brest - Hôpital La Cavale Blanche, Brest, France
Contact: Study coordinator (Ombeline PAGLIA)CHU Caen, Caen, France
Contact: Study coordinator (Fabien LABOMBARDA)CHU Dijon - Hôpital François Mitterrand, Dijon, France
Contact: Study coordinator (Jean-Christophe EICHER)CHU Grenoble Alpes, Grenoble, France
Contact: Study coordinator (Gilles Barone-Rochette, Pr)CHU Lille, Lille, France
Contact: Study coordinator (RIDON Hélène)APHM - Hôpital La Timone, Marseille, France
Contact: Study coordinator (HABIB Gilbert)CHU de Nantes -Hôpital Nord Laennec, Nantes, France
Contact: Study coordinator (Nicolas PIRIOU)AP-HP Höpital la Pitié-Salpétrière, Paris, France
Contact: Study coordinator (Philippe CHARRON)APHP Hopital Européen Georges Pompidou, Paris, France
Contact: Study coordinator (Nadia AISSAOUI)APHP, Hôpital Lariboisière, Paris, France
Contact: Study coordinator (Damien LOGEART)CHU Rennes - Hôpital Pontchaillou, Rennes, France
Contact: Study coordinator (DONAL Erwan)CHU de Rouen, Rouen, France
Contact: Study coordinator (Charles FAUVEL)CHU Rangueil Toulouse, Toulouse, France
Contact: Study coordinator (Eve Cariou)CHU de TOURS - HOPITAL TROUSSEAU, Tours, France
Contact: Study coordinator (Anne BERNARD)CHU Nancy, Vandœuvre-lès-Nancy, France
Contact: Study coordinator (Olivier HUTTIN)
Study leads
Donal Erwan
Principal Investigator
Rennes University Hospital